ISSN 1016-5169 | E-ISSN 1308-4488
pdf
Management of tachyarrhythmia during pregnancy [Turk Kardiyol Dern Ars]
Turk Kardiyol Dern Ars. 2017; 45(2): 189-196 | DOI: 10.5543/tkda.2016.78606

Management of tachyarrhythmia during pregnancy

Emily Ann Enderlin1, Khaldia Taufiq Khaled2, Luke Oke3, Mohammed Madmani4, Hakan Paydak3
1College of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
2Department of Internal Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA
3Department of Clinical Cardiac Electrophysiology, University of Arkansas for Medical Sciences, Lit
4Department of Cardiovascular Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA

Maternal tachyarrhythmia is a common complication during pregnancy due to hormonal changes that enhance pre-existing arrhythmias or induce new arrhythmias in the presence of congenital heart defects in pregnant females. Presence of tachyarrhythmia during pregnancy poses risk to the mother and fetus, calling for proper treatment with medications. Use of antiarrhythmic drugs in cases of maternal tachyarrhythmia must give due consideration of potential teratogenic side effects. Utilization of antiarrhythmic drugs during pregnancy has been well studied; some result in minimal fetal harm or none at all. New techniques, such as cardiac ablation, have also been implemented with minimal or no radiation exposure to the fetus or mother. Pregnant women with tachyarrhythmia have been successfully treated with little to no impact on the developing fetus as result of increasing experience with antiarrhythmic drugs and progress of new procedural techniques.

Keywords: Anti-arrhythmic agent, atrial tachycardia, pregnancy, premature atrial complex; premature ventricular complex; supraventricular tachycardia; tachyarrhythmia; ventricular tachycardia.

How to cite this article
Emily Ann Enderlin, Khaldia Taufiq Khaled, Luke Oke, Mohammed Madmani, Hakan Paydak. Management of tachyarrhythmia during pregnancy. Turk Kardiyol Dern Ars. 2017; 45(2): 189-196

Corresponding Author: Emily Ann Enderlin, United States
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2024 Archives of the Turkish Society of Cardiology



Kare Publishing is a subsidiary of Kare Media.